Charles A. Kunos

Role of stereotactic radiosurgery in gynecologic cancer.

Cabazitaxel-induced stabilization of microtubules enhances radiosensitivity in ovarian cancer cells.

Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator.

Comparison of helical tomotherapy versus conventional radiation to deliver craniospinal radiation.

Radiation therapy in addition to gross total resection of retroperitoneal sarcoma results in prolonged survival: results from a single institutional study.

Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein.

Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer.

Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer.

Ribonucleotide reductase inhibition enhances chemoradiosensitivity of human cervical cancers.

Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group.

Radiosensitization of human cervical cancer cells by inhibiting ribonucleotide reductase: enhanced radiation response at low-dose rates.

Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancers.

Chemotherapy plus radiation in advanced-stage endometrial cancer.

Robotic surgery in gynecologic oncology.

On model ensemble analyses of nonmonotonic data.

Management of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone-induced methemoglobinemia.

Hematological toxicity after robotic stereotactic body radiosurgery for treatment of metastatic gynecologic malignancies.

Therapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer.

Elevated ribonucleotide reductase levels associate with suppressed radiochemotherapy response in human cervical cancers.

dNTP Supply Gene Expression Patterns after P53 Loss.

Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies.

Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis.

Emerging role of stereotactic body radiotherapy in the treatment of pancreatic cancer.

Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers.

Radiation quality, like art, consists in drawing the line somewhere.

Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.

Acute gastrointestinal toxicity after robotic stereotactic ablative radiotherapy for treatment of metastatic gynecological malignancies.

Novel biological radiochemotherapy approaches in locally advanced-stage cervical cancer management.

Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical Cancer.

Hydration during breast radiotherapy may lower skin toxicity.

Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer.

Two-step procedure for evaluating experimentally induced DNA damage: Texas Red and Comet assays.

Molecular Strategies of Deoxynucleotide Triphosphate Supply Inhibition Used in the Treatment of Gynecologic Malignancies.

(18)FDG-PET/CT Definition of Clinical Target Volume for Robotic Stereotactic Body Radiosurgery Treatment of Metastatic Gynecologic Malignancies.

Determination of triapine, a ribonucleotide reductase inhibitor, in human plasma by liquid chromatography tandem mass spectrometry.